2026. Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase. Canadian Dermatology Today. 7, 3 (Sep. 2026), 4–10. DOI:https://doi.org/10.58931/cdt.2026.73167.